CompoAtlas

THE(ザ)ラフマ葉: notification withdrawn

THE(ザ)ラフマ葉: notification withdrawn : Food with function claims notified in Japan. This notification does not constitute authorisation for sale in France or the European Union. It does not demonstrate the safety or efficacy of the product.

CAA, Japan Foods with Function Claims notifications, retrieval date unknown.

Source : Agence de la consommation du Japon (CAA), https://www.fld.caa.go.jp/caaks/s/cssc01/. Données traitées par CompoAtlas à partir de l'export officiel ; cette présentation est celle de CompoAtlas et n'est pas publiée telle quelle par l'État japonais. Public Data License 1.0.

Public Data License 1.0 (公共データ利用規約 第1.0版), compatible CC BY 4.0

Registration number
H608
Type
Processed food (tablets, capsules and similar forms)
Published status
Notification withdrawn
Notifier
武内製薬株式会社
Notification date
2022-10-07
Modification date
2025-10-21
Withdrawal date
2026-03-17

Notification under the company’s responsibility, without prior review by the Japanese state. The Japanese category does not determine the regulatory category of the product in France.

French and European references for recognised ingredients

Unidentified ingredients are not assessed. The absence of a signal does not establish product compliance.

Published composition

Published ingredientPublished text and quantityIdentified nutrient or substance
ラフマ由来ヒペロシドラフマ由来ヒペロシド : 1 mg (par jour)Not identified
ラフマ由来イソクエルシトリンラフマ由来イソクエルシトリン : 1 mg (par jour)Not identified

Daily quantities are reproduced as declared, without estimation or conversion. A quantity is associated with an ingredient only when the name and match are unambiguous. Japanese names and texts are retained without translation. No comparison with dose limits is performed.

Name (original Japanese text)

ラフマ葉抽出物含有加工食品

Declared claim (original Japanese text)

本品にはラフマ由来ヒペロシド、ラフマ由来イソクエルシトリンが含まれます。ラフマ由来ヒペロシド、ラフマ由来イソクエルシトリンには睡眠の質(眠りの深さ・起床時の睡眠に対する満足感)の向上に役立つことが報告されています。

Precautions (original Japanese text)

/

Reason for withdrawal (original Japanese text)

販売終了のため

Raw materials of functional ingredients (original Japanese text)

ラフマ葉抽出物

就寝前に1日1粒を目安に水などと一緒にお召し上がりください。

Method of consumption (original Japanese text)

就寝前に1日1粒を目安に水などと一緒にお召し上がりください。(一日摂取目安量と併せて表示)

Ingredient names for daily quantities (original Japanese text)

ラフマ由来ヒペロシド、ラフマ由来イソクエルシトリン

Declared daily quantities (original Japanese text)

ラフマ由来ヒペロシド:1 mg、ラフマ由来イソクエルシトリン:1 mg

A claim declared in Japan is not an authorised health claim in the European Union. See the health claims register.

Original register data

View published fields and their variants
Functional component amount
ラフマ由来ヒペロシド:1 mg、ラフマ由来イソクエルシトリン:1 mg
Functional component
ラフマ由来ヒペロシド、ラフマ由来イソクエルシトリン
Published daily intake
就寝前に1日1粒を目安に水などと一緒にお召し上がりください。
Published designation
ラフマ葉抽出物含有加工食品
Product name
THE(ザ)ラフマ葉
Published last update
2025/10/21
Reason for withdrawal
販売終了のため
Publication date
2022/10/07
Notification number
H608
Published intake method
就寝前に1日1粒を目安に水などと一緒にお召し上がりください。(一日摂取目安量と併せて表示)
Published precautions
/
Declared withdrawal
1
Withdrawal date
2026/03/17
Official scientific dossier
https://www.fld.caa.go.jp/caaks/s/cssc01/fwccd01?c__id=a09F900004sk8mpIAA
Functional component
ラフマ由来ヒペロシド、ラフマ由来イソクエルシトリン
Company
武内製薬株式会社
Claimed function in the source
本品にはラフマ由来ヒペロシド、ラフマ由来イソクエルシトリンが含まれます。ラフマ由来ヒペロシド、ラフマ由来イソクエルシトリンには睡眠の質(眠りの深さ・起床時の睡眠に対する満足感)の向上に役立つことが報告されています。
Product category
加工食品(錠剤、カプセル剤等)
Published marketing status
販売休止中
Functional component raw materials
ラフマ葉抽出物

Official source

View the official register, number H608

Source : Agence de la consommation du Japon (CAA), https://www.fld.caa.go.jp/caaks/s/cssc01/. Données traitées par CompoAtlas à partir de l'export officiel ; cette présentation est celle de CompoAtlas et n'est pas publiée telle quelle par l'État japonais. Public Data License 1.0.

Public Data License 1.0 (公共データ利用規約 第1.0版), compatible CC BY 4.0

List in the official revision dated (register: CAA, Japan Foods with Function Claims notifications).

Has the product changed? Photograph the packaging.

Enter to analyse, Shift+Enter for a new line